2-73385903-T-TGGAGGAGGA

Variant summary

Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP3BP6BS1BS2

The NM_001378454.1(ALMS1):​c.66_74dupGGAGGAGGA​(p.Glu23_Glu25dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0025 ( 2 hom., cov: 0)
Exomes 𝑓: 0.0039 ( 1 hom. )

Consequence

ALMS1
NM_001378454.1 disruptive_inframe_insertion

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:12

Conservation

PhyloP100: 0.369
Variant links:
Genes affected
ALMS1 (HGNC:428): (ALMS1 centrosome and basal body associated protein) This gene encodes a protein containing a large tandem-repeat domain as well as additional low complexity regions. The encoded protein functions in microtubule organization, particularly in the formation and maintanance of cilia. Mutations in this gene cause Alstrom syndrome. There is a pseudogene for this gene located adjacent in the same region of chromosome 2. Alternative splice variants have been described but their full length nature has not been determined. [provided by RefSeq, Apr 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -10 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_001378454.1
BP6
Variant 2-73385903-T-TGGAGGAGGA is Benign according to our data. Variant chr2-73385903-T-TGGAGGAGGA is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 193379.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=4, Benign=3, Uncertain_significance=1}.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.00255 (366/143614) while in subpopulation SAS AF= 0.0136 (58/4258). AF 95% confidence interval is 0.0108. There are 2 homozygotes in gnomad4. There are 182 alleles in male gnomad4 subpopulation. Median coverage is 0. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALMS1NM_001378454.1 linkc.66_74dupGGAGGAGGA p.Glu23_Glu25dup disruptive_inframe_insertion Exon 1 of 23 ENST00000613296.6 NP_001365383.1
ALMS1NM_015120.4 linkc.66_74dupGGAGGAGGA p.Glu23_Glu25dup disruptive_inframe_insertion Exon 1 of 23 NP_055935.4 Q8TCU4
LOC105374804XR_007087045.1 linkn.-231_-223dupTCCTCCTCC upstream_gene_variant
LOC105374804XR_007087053.1 linkn.-231_-223dupTCCTCCTCC upstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALMS1ENST00000613296.6 linkc.66_74dupGGAGGAGGA p.Glu23_Glu25dup disruptive_inframe_insertion Exon 1 of 23 1 NM_001378454.1 ENSP00000482968.1 Q8TCU4-1

Frequencies

GnomAD3 genomes
AF:
0.00255
AC:
366
AN:
143510
Hom.:
2
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.000778
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00450
Gnomad ASJ
AF:
0.00151
Gnomad EAS
AF:
0.00718
Gnomad SAS
AF:
0.0136
Gnomad FIN
AF:
0.00128
Gnomad MID
AF:
0.00355
Gnomad NFE
AF:
0.00239
Gnomad OTH
AF:
0.00307
GnomAD3 exomes
AF:
0.00428
AC:
357
AN:
83366
Hom.:
4
AF XY:
0.00456
AC XY:
199
AN XY:
43654
show subpopulations
Gnomad AFR exome
AF:
0.000456
Gnomad AMR exome
AF:
0.00683
Gnomad ASJ exome
AF:
0.000937
Gnomad EAS exome
AF:
0.00666
Gnomad SAS exome
AF:
0.0106
Gnomad FIN exome
AF:
0.000717
Gnomad NFE exome
AF:
0.00108
Gnomad OTH exome
AF:
0.00325
GnomAD4 exome
AF:
0.00389
AC:
2169
AN:
557620
Hom.:
1
Cov.:
0
AF XY:
0.00433
AC XY:
1288
AN XY:
297754
show subpopulations
Gnomad4 AFR exome
AF:
0.000570
Gnomad4 AMR exome
AF:
0.00637
Gnomad4 ASJ exome
AF:
0.00142
Gnomad4 EAS exome
AF:
0.0142
Gnomad4 SAS exome
AF:
0.0117
Gnomad4 FIN exome
AF:
0.00116
Gnomad4 NFE exome
AF:
0.00210
Gnomad4 OTH exome
AF:
0.00289
GnomAD4 genome
AF:
0.00255
AC:
366
AN:
143614
Hom.:
2
Cov.:
0
AF XY:
0.00261
AC XY:
182
AN XY:
69648
show subpopulations
Gnomad4 AFR
AF:
0.000776
Gnomad4 AMR
AF:
0.00456
Gnomad4 ASJ
AF:
0.00151
Gnomad4 EAS
AF:
0.00720
Gnomad4 SAS
AF:
0.0136
Gnomad4 FIN
AF:
0.00128
Gnomad4 NFE
AF:
0.00238
Gnomad4 OTH
AF:
0.00304

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:12
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:6
Jul 16, 2021
GeneDx
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Dec 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

ALMS1: BS1 -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Apr 27, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Alstrom syndrome Uncertain:1Benign:3
Oct 11, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Mar 05, 2018
Genomic Research Center, Shahid Beheshti University of Medical Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Nov 01, 2019
Natera, Inc.
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Benign:2
-
Clinical Genetics, Academic Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Oct 20, 2014
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Cardiovascular phenotype Benign:1
Nov 19, 2018
Ambry Genetics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs55889738; hg19: chr2-73613031; API